TV News LIES

Thursday, Aug 28th

Last update07:43:56 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


CDC erupts in chaos after ousted chief Susan Monarez refuses to resign

Susan Monarez refuses to resignThe US’s top public health agency was plunged into chaos on Wednesday after the Trump administration...

FDA reinstates ousted top vaccine regulator Vinay Prasad

FDA vaccine expert reinstatedVinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last...

CDC Director Susan Monarez ousted just weeks after confirmation

Susan MonarezSusan Monarez, the longtime government scientist recently confirmed as director of the Centers for Disease Control...

Largest National Org Of OB-GYNs Cuts Financial Ties With Trump Admin

ACOGThe country’s largest organization of OB-GYN providers announced this week that it will stop accepting funds...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!